| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALGS | Exit | ALIGOS THERAPEUTICS INC | $0 | – | -743,215 | -100.0% | -0.22% | – |
| Exit | IO BIOTECH INC | $0 | – | -864,197 | -100.0% | -0.49% | – | |
| BOLT | Exit | BOLT BIOTHERAPEUTICS INC | $0 | – | -1,891,467 | -100.0% | -0.78% | – |
| Exit | VIGIL NEUROSCIENCE INC | $0 | – | -560,595 | -100.0% | -1.20% | – | |
| Exit | EXSCIENTIA PLCads | $0 | – | -770,500 | -100.0% | -1.39% | – | |
| GRCL | Exit | GRACELL BIOTECHNOLOGIES INCsponsored ads | $0 | – | -1,375,000 | -100.0% | -1.58% | – |
| FUSN | Exit | FUSION PHARMACEUTICALS INC | $0 | – | -1,560,982 | -100.0% | -1.62% | – |
| ARQT | Exit | ARCUTIS BIOTHERAPEUTICS INC | $0 | – | -1,105,309 | -100.0% | -2.34% | – |
| Exit | RALLYBIO CORP | $0 | – | -2,404,644 | -100.0% | -3.23% | – | |
| INZY | Exit | INOZYME PHARMA INC | $0 | – | -4,494,851 | -100.0% | -7.53% | – |
| Exit | OCULIS HOLDING AGordinary shares | $0 | – | -2,218,754 | -100.0% | -9.74% | – | |
| PCVX | Exit | VAXCYTE INC | $0 | – | -793,036 | -100.0% | -16.12% | – |
| KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -797,008 | -100.0% | -53.75% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KARUNA THERAPEUTICS INC | 12 | Q3 2023 | 65.4% |
| VAXCYTE INC | 12 | Q3 2023 | 19.5% |
| INOZYME PHARMA INC | 12 | Q3 2023 | 10.8% |
| ARCUTIS BIOTHERAPEUTICS INC | 12 | Q3 2023 | 6.2% |
| FUSION PHARMACEUTICALS INC | 12 | Q3 2023 | 6.2% |
| ALIGOS THERAPEUTICS INC | 12 | Q3 2023 | 8.0% |
| BOLT BIOTHERAPEUTICS INC | 11 | Q3 2023 | 20.0% |
| RALLYBIO CORP | 9 | Q3 2023 | 14.1% |
| AKOUOS INC | 8 | Q3 2022 | 11.7% |
| EXSCIENTIA PLC | 8 | Q3 2023 | 6.4% |
View Pivotal bioVenture Partners Investment Advisor LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View Pivotal bioVenture Partners Investment Advisor LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.